SCHEMBL6103160

SCHEMBL6103160

Cc1ccc(S(=O)(=O)c2ccc(Cl)cc2)cc1S(=O)(=O)NCCc1ccc(Cl)c(Cl)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SFRP1 Q8N474 2/20 0.64
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
ALDH1A1 P00352 3/20 0.48
LMNA P02545 3/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
TBXA2R P21731 3/20 0.46
TP53 P04637 1/20 0.46
MAPT P10636 1/20 0.46
CDK1 P06493 1/20 0.45
CCNB1 P14635 1/20 0.45
CCNA2 P20248 1/20 0.45
CDK2 P24941 1/20 0.45
CDK7 P50613 1/20 0.45
CCNH P51946 1/20 0.45
CCNA1 P78396 1/20 0.45
POLB P06746 2/20 0.45
LSS P48449 1/20 0.45
HPGD P15428 1/20 0.45
PDK1 Q15118 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4617221 0.93 SFRP1 (0.64) SFRP1MEN1KMT2AALDH1A1LMNA
SCHEMBL4618169 0.92 SFRP1 (0.77) SFRP1MEN1KMT2AALDH1A1LMNA
SCHEMBL6103295 0.92 SFRP1 (0.75) SFRP1MEN1KMT2AALDH1A1LMNA
SCHEMBL4615867 0.91 SFRP1 (0.61) SFRP1MEN1KMT2AALDH1A1LMNA
SCHEMBL4618988 0.88 SFRP1 (0.70) SFRP1MEN1KMT2AALDH1A1LMNA
SCHEMBL4616990 0.88 SFRP1 (0.70) SFRP1MEN1KMT2AALDH1A1LMNA
SCHEMBL4617976 0.87 SFRP1 (0.84) SFRP1MEN1KMT2AALDH1A1TBXA2R
SCHEMBL4616020 0.86 SFRP1 (0.67) SFRP1MEN1KMT2AALDH1A1LMNA
SCHEMBL4618849 0.86 SFRP1 (0.67) SFRP1MEN1KMT2AALDH1A1LMNA
SCHEMBL4617918 0.86 MEN1 (0.69) SFRP1MEN1KMT2AALDH1A1TBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 SFRP1 1/4885MEN1 886/4885KMT2A 3832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.